Xeme Biopharma

Chemicals & Related Products · Illinois, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1120 N Du Page Ave, Lombard, Illinois, 6...

Phone Number

(844) 709-9363

Revenue

<$5 Million

Industry

Chemicals & Related Products Manufacturing Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Xeme Biopharma

XEME Biopharma Inc. is a clinical-stage company dedicated to developing innovative therapeutic cancer vaccines, focusing on active cancer immunotherapy. The company operates under FDA guidance and aims to advance cancer treatment beyond traditional methods such as surgery and chemotherapy. XEME utilizes two integrated technology platforms, Aggregon and Oncolipin, to manufacture personalized cancer vaccines, specifically targeting leukemia and lymphoma. Their lead products include Oncoquest-CLL and Oncoquest-L, designed for personalized treatment approaches.Explore more
Popular SearchesXEME Biopharma IncBiopharma IncXEME BiopharmaXeme Bio Pharma IncSIC Code 28,283NAICS Code 32,325Show more

Xeme Biopharma Org Chart

PhoneEmail
RR
United States flag for contact location.

Founder & Vice President, Research, Developme...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Xeme Biopharma your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Xeme Biopharma

Compare insights from companies similar to Xeme Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Xeme Biopharma

<$5M
11-50
Private
-
2005
RR
Richard RobbFounder & Vice President, Research, Development & Quality Assurance
$5.3M
11-50
Private
$83.5M
2005
<$5M
1-10
Private
-
2012
N/A
<$5M
1-10
Private
-
2012
LH
Lauren HartmannManager, Clinical Trial & Consultant
<$5M
1-10
Public
$25.4M
2012
LB
Lewis BenderFounder, President & CEO
<$5M
1-10
Private
$6.7M
2011
Gregory Wilson, Chief Financial Officer at OncoSynergy
Gregory WilsonChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Xeme Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Xeme Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xeme Biopharma.

Xeme Biopharma Tech Stack

A closer look at the technologies used by Xeme Biopharma

Top Chemicals & Related Products Companies

Frequently Asked Questions Regarding Xeme Biopharma

What is Xeme Biopharma's official website?
Xeme Biopharma's official website is www.xemebiopharma.com
What is Xeme Biopharma's Revenue?
Xeme Biopharma's revenue is <$5 Million
What is Xeme Biopharma's SIC code?
Xeme Biopharma's SIC: 28,283
What is Xeme Biopharma's NAICS code?
Xeme Biopharma's NAICS: 32,325
How many employees does Xeme Biopharma have?
Xeme Biopharma has 11-50 employees
What industry does Xeme Biopharma belong to?
Xeme Biopharma is in the industry of: Chemicals & Related Products, Manufacturing, Business Services
What is Xeme Biopharma competition?
Xeme Biopharma top competitors include: Intensity Therapeutics, Veana Therapeutics, Immunomic Therapeutics, Immunova Therapeutics
What technology does Xeme Biopharma use?
Some of the popular technologies that Xeme Biopharma uses are: Sentry, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager, Wix
How do I contact Xeme Biopharma?
Xeme Biopharma contact info: Phone number: (844) 709-9363 Website: www.xemebiopharma.com
What does Xeme Biopharma do?

XEME Biopharma Inc. is a clinical-stage company dedicated to developing innovative therapeutic cancer vaccines, focusing on active cancer immunotherapy. The company operates under FDA guidance and aims to advance cancer treatment beyond traditional methods such as surgery and chemotherapy. XEME utilizes two integrated technology platforms, Aggregon... and Oncolipin, to manufacture personalized cancer vaccines, specifically targeting leukemia and lymphoma. Their lead products include Oncoquest-CLL and Oncoquest-L, designed for personalized treatment approaches.Read More

Is Xeme Biopharma a public company?
Xeme Biopharma is private company therefore does not currently have an official ticker symbol
See more information about Xeme Biopharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.